Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell(University of Cambridge), Peter J. Campbell(Wellcome Sanger Institute), David C. Wedge(University of Manchester), Ben Challacombe(Guy's and St Thomas' NHS Foundation Trust), Nicos Fotiadis(Royal Marsden NHS Foundation Trust), Lavinia Spain(Royal Marsden NHS Foundation Trust), Keiran Raine(Wellcome Sanger Institute), Andy G. Lynch(University of St Andrews), Kevin Litchfield(Cancer Research UK), Nicos Angelopoulos(Wellcome Sanger Institute), Charles Swanton(The Francis Crick Institute), Aengus Stewart(University of the Basque Country), Iñigo Martincorena(Wellcome Sanger Institute), Zoltán Szállási(Semmelweis University), Lisa Pickering(Royal Marsden Hospital), Lucy Yates(University of Cambridge), Gordon Stamp(Royal Marsden Hospital), Samra Turajlic(Royal Marsden NHS Foundation Trust), José I. López(BioCruces Health research Institute), Patrick Tarpey(Wellcome Sanger Institute), Joanna Lynch(Royal Marsden NHS Foundation Trust), Andrew Rowan(Cancer Institute (WIA)), Nicholas McGranahan(CRUK Lung Cancer Centre of Excellence), István Csabai(Eötvös Loránd University), Stéphane Oudard(Assistance Publique – Hôpitaux de Paris), Ashish Chandra(Guy's Hospital), Réza Elaidi(Hôpital Européen Georges-Pompidou), Lewis Au(Royal Marsden NHS Foundation Trust), P. Andrew Futreal(Wellcome Sanger Institute), Aspasia Soultati, James Larkin(Trinity College Dublin), Grant D. Stewart(University of Cambridge), Tim Chambers(University of Canterbury), Mark Stares(Edinburgh Cancer Research), James H. R. Farmery(University of Cambridge), Francesco Maura(Memorial Sloan Kettering Cancer Center), Hang Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), David Nicol(Royal Stoke University Hospital), Jon W. Teague(Wellcome Sanger Institute), Sarah Rudman(Guy's and St Thomas' NHS Foundation Trust), Archana Fernando(Guy's and St Thomas' NHS Foundation Trust), Adam P. Butler(Wellcome Sanger Institute), Simon Chowdhury(Sarah Cannon Research Institute), Tim O’Brien(St Thomas' Hospital), Stuart Horswell(The Francis Crick Institute), Martin Gore(Imperial College London), Steve Hazell(Royal Marsden NHS Foundation Trust)
Cited by 565
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
The Sloan Digital Sky Survey: Technical Summary
|The Astronomical Journal|2000|10.5k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k